BC-12-VG35_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, N-{3-[6-(3,6-Dihydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-5-fluoro-2-methyl-phenyl}-2-fluoro-4-(1-hydroxy-1-methyl-ethyl)-benzamide, reversible BTK inhibitor targeting BTK (Novartis, 71230655)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/71230655
Similar Terms
Downloads & Tools

Genes

10 genes differentially expressed following the BC-12-VG35_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.454622
DLGAP2 discs, large (Drosophila) homolog-associated protein 2 0.298584
RPS17 ribosomal protein S17 0.261556
RPS12 ribosomal protein S12 0.227035
RPS23 ribosomal protein S23 0.218022

decreased expression

Symbol Name Standardized Value
RAB35 RAB35, member RAS oncogene family -0.345989
TAF15 TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa -0.298584
SPATS2 spermatogenesis associated, serine-rich 2 -0.298584
CTIF CBP80/20-dependent translation initiation factor -0.258634
MAP1S microtubule-associated protein 1S -0.21664